AI Article Synopsis

  • Microtubule acetylation impacts actin filament dynamics by influencing signaling pathways, but the exact processes are still unclear.
  • Disruption of ATAT1 reduces microtubule acetylation, leading to lower RhoA levels, which are crucial for actin organization and stress fiber formation.
  • C/EBPβ is a key regulator of RhoA, and its fragment C/EBPβp27, formed by cathepsin L in ATAT1 knockout cells, inhibits RhoA expression, suggesting potential targets for breast cancer therapies.

Article Abstract

Microtubule acetylation has been shown to regulate actin filament dynamics by modulating signaling pathways that control actin organization, although the precise mechanisms remain unknown. In this study, we found that the downregulation of microtubule acetylation via the disruption ATAT1 (which encodes α-tubulin N-acetyltransferase 1) inhibited the expression of RhoA, a small GTPase involved in regulating the organization of actin filaments and the formation of stress fibers. Analysis of RHOA promoter and chromatin immunoprecipitation assays revealed that C/EBPβ is a major regulator of RHOA expression. Interestingly, the majority of C/EBPβ in ATAT1 knockout (KO) cells was found in the nucleus as a 27-kDa fragment (referred to as C/EBPβp27) lacking the N-terminus of C/EBPβ. Overexpression of a gene encoding a C/EBPβp27-mimicking protein via an N-terminal deletion in C/EBPβ led to competitive binding with wild-type C/EBPβ at the C/EBPβ binding site in the RHOA promoter, resulting in a significant decrease of RHOA expression. We also found that cathepsin L (CTSL), which is overexpressed in ATAT1 KO cells, is responsible for C/EBPβp27 formation in the nucleus. Treatment with a CTSL inhibitor led to the restoration of RHOA expression by downregulation of C/EBPβp27 and the invasive ability of ATAT1 KO MDA-MB-231 breast cancer cells. Collectively, our findings suggest that the downregulation of microtubule acetylation associated with ATAT1 deficiency suppresses RHOA expression by forming C/EBPβp27 in the nucleus through CTSL. We propose that CTSL and C/EBPβp27 may represent a novel therapeutic target for breast cancer treatment. [BMB Reports 2024; 57(6): 293-298].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11214891PMC
http://dx.doi.org/10.5483/BMBRep.2023-0230DOI Listing

Publication Analysis

Top Keywords

rhoa expression
16
microtubule acetylation
12
disruption atat1
8
rhoa
8
downregulation microtubule
8
rhoa promoter
8
breast cancer
8
c/ebpβ
7
atat1
6
expression
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!